Table 4.
Clearly Stated Aim | Inclusion of Consecutive Patients | Prospective Collection of Data | Endpoints Appropriate to the Aim of the Study | Unbiased Assessment of the Study Endpoint | Follow-Up Period Appropriate to the Aim of the Study | Loss to Follow-Up Less than 5% | Prospective Calculation of the Study Size | * An Adequate Control Group | * Contemporary Groups | * Baseline Equivalence of Groups | * Adequate Statistical Analyses | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thakur et al., 2013 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 21 |
Zavattini et al., 2020 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 22 |
The items are scored 0 (not reported), 1 (reported but inadequate) or 2 (reported and adequate). The global ideal score is 16 for non-comparative studies and 24 for comparative studies. * For study with control group.